Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 5
2011 2
2012 1
2014 2
2015 4
2016 7
2017 4
2018 1
2019 6
2020 10
2021 9
2022 16
2023 8
2024 14
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.
Cortazar FB, Kibbelaar ZA, Glezerman IG, Abudayyeh A, Mamlouk O, Motwani SS, Murakami N, Herrmann SM, Manohar S, Shirali AC, Kitchlu A, Shirazian S, Assal A, Vijayan A, Renaghan AD, Ortiz-Melo DI, Rangarajan S, Malik AB, Hogan JJ, Dinh AR, Shin DS, Marrone KA, Mithani Z, Johnson DB, Hosseini A, Uprety D, Sharma S, Gupta S, Reynolds KL, Sise ME, Leaf DE. Cortazar FB, et al. Among authors: abudayyeh a. J Am Soc Nephrol. 2020 Feb;31(2):435-446. doi: 10.1681/ASN.2019070676. Epub 2020 Jan 2. J Am Soc Nephrol. 2020. PMID: 31896554 Free PMC article.
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.
Murakami N, Mulvaney P, Danesh M, Abudayyeh A, Diab A, Abdel-Wahab N, Abdelrahim M, Khairallah P, Shirazian S, Kukla A, Owoyemi IO, Alhamad T, Husami S, Menon M, Santeusanio A, Blosser CD, Zuniga SC, Soler MJ, Moreso F, Mithani Z, Ortiz-Melo D, Jaimes EA, Gutgarts V, Lum E, Danovitch GM, Cardarelli F, Drews RE, Bassil C, Swank JL, Westphal S, Mannon RB, Shirai K, Kitchlu A, Ong S, Machado SM, Mothi SS, Ott PA, Rahma O, Hodi FS, Sise ME, Gupta S, Leaf DE, Devoe CE, Wanchoo R, Nair VV, Schmults CD, Hanna GJ, Sprangers B, Riella LV, Jhaveri KD; Immune Checkpoint Inhibitors in Solid Organ Transplant Consortium. Murakami N, et al. Among authors: abudayyeh a. Kidney Int. 2021 Jul;100(1):196-205. doi: 10.1016/j.kint.2020.12.015. Epub 2020 Dec 24. Kidney Int. 2021. PMID: 33359528 Free PMC article.
Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study.
Gupta S, Glezerman IG, Hirsch JS, Chen KL, Devaraj N, Wells SL, Seitter RH, Kaunfer SA, Jose AM, Rao SP, Ortega JL, Green-Lingren O, Hayden R, Bendapudi PK, Chute DF, Sise ME, Jhaveri KD, Page VD, Abramson MH, Motwani SS, Xu W, Sehgal K, Reynolds KL, Bansal A, Abudayyeh A, Leaf DE. Gupta S, et al. Among authors: abudayyeh a. BMJ. 2024 Mar 27;384:e077169. doi: 10.1136/bmj-2023-077169. BMJ. 2024. PMID: 38538012 Free PMC article.
A family's sacrifice.
Abudayyeh AM. Abudayyeh AM. Science. 2024 Jun 14;384(6701):1270. doi: 10.1126/science.adq9622. Epub 2024 Jun 13. Science. 2024. PMID: 38870310 No abstract available.
Assessment of GFR in Patients with Cancer: A Statement from the American Society of Onco-Nephrology.
Kitchlu A, Silva VTCE, Anand S, Kala J, Abudayyeh A, Inker LA, Rosner MH, Karam S, Gudsoorkar P, Gupta S, Chen S, Klomjit N, Leung N, Milanez T, Motwani SS, Khalid SB, Srinivasan V, Wanchoo R, Beumer JH, Liu G, Tannir NM, Orchanian-Cheff A, Geng Y, Herrmann SM. Kitchlu A, et al. Among authors: abudayyeh a. Clin J Am Soc Nephrol. 2024 Aug 1;19(8):1061-1072. doi: 10.2215/CJN.0000000000000508. Epub 2024 Jun 7. Clin J Am Soc Nephrol. 2024. PMID: 38848131
Diagnosis and management of immune checkpoint inhibitor-associated nephrotoxicity: a position statement from the American Society of Onco-nephrology.
Herrmann SM, Abudayyeh A, Gupta S, Gudsoorkar P, Klomjit N, Motwani SS, Karam S, Costa E Silva VT, Khalid SB, Anand S, Kala J, Leaf DE, Murakami N, Rashidi A, Wanchoo R, Kitchlu A. Herrmann SM, et al. Among authors: abudayyeh a. Kidney Int. 2025 Jan;107(1):21-32. doi: 10.1016/j.kint.2024.09.017. Epub 2024 Oct 24. Kidney Int. 2025. PMID: 39455026
Acute kidney injury in patients treated with immune checkpoint inhibitors.
Gupta S, Short SAP, Sise ME, Prosek JM, Madhavan SM, Soler MJ, Ostermann M, Herrmann SM, Abudayyeh A, Anand S, Glezerman I, Motwani SS, Murakami N, Wanchoo R, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, Seigneux S, Campedel L, Kitchlu A, Shin DS, Rangarajan S, Deshpande P, Coppock G, Eijgelsheim M, Seethapathy H, Lee MD, Strohbehn IA, Owen DH, Husain M, Garcia-Carro C, Bermejo S, Lumlertgul N, Seylanova N, Flanders L, Isik B, Mamlouk O, Lin JS, Garcia P, Kaghazchi A, Khanin Y, Kansal SK, Wauters E, Chandra S, Schmidt-Ott KM, Hsu RK, Tio MC, Sarvode Mothi S, Singh H, Schrag D, Jhaveri KD, Reynolds KL, Cortazar FB, Leaf DE; ICPi-AKI Consortium Investigators. Gupta S, et al. Among authors: abudayyeh a. J Immunother Cancer. 2021 Oct;9(10):e003467. doi: 10.1136/jitc-2021-003467. J Immunother Cancer. 2021. PMID: 34625513 Free PMC article.
Renal Toxicity.
Abdelrahim M, Abudayyeh A. Abdelrahim M, et al. Among authors: abudayyeh a. Adv Exp Med Biol. 2021;1342:389-397. doi: 10.1007/978-3-030-79308-1_16. Adv Exp Med Biol. 2021. PMID: 34972976 Review.
Renal Toxicity.
Abdelrahim M, Abudayyeh A. Abdelrahim M, et al. Among authors: abudayyeh a. Adv Exp Med Biol. 2020;1244:287-293. doi: 10.1007/978-3-030-41008-7_16. Adv Exp Med Biol. 2020. PMID: 32301023 Review.
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury.
Gupta S, Glezerman IG, Hirsch JS, Chewcharat A, Wells SL, Ortega JL, Pirovano M, Kim R, Chen KL, Jhaveri KD, Page VD, Abramson MH, Bansal A, Ghimire A, Joy MS, Abudayyeh A, Leaf DE. Gupta S, et al. Among authors: abudayyeh a. JAMA Oncol. 2025 Jun 1;11(6):636-643. doi: 10.1001/jamaoncol.2025.0756. JAMA Oncol. 2025. PMID: 40272825
85 results